Siatis Perry C, of AbbVie Inc. (NYSE:ABBV), sold 4,619 shares of company stock on March 02, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The shares were sold at an average price of $235.26 per share, for a total transaction value of $611.7K. Following this transaction, Siatis Perry C still owns 4,619 shares of AbbVie Inc. stock.
AbbVie Inc.'s stock currently trades at $233.86, giving the company a market capitalization of $410.1B.
Insider sales are common and don't necessarily indicate a bearish outlook. Executives regularly sell shares for tax planning, diversification, or personal liquidity. The key factors to watch are the size of the sale relative to the insider's total holdings, whether multiple insiders are selling simultaneously, and whether the trades occur near earnings announcements or other catalysts.
This $612K transaction is a notable data point for investors tracking insider sentiment at AbbVie Inc.. While any single trade should be viewed in context, patterns of insider activity over time can provide valuable directional signals.
Insider transaction data is reported to the SEC via Form 4 filings, typically within two business days of the trade. Investors can track insider activity alongside other metrics — such as institutional flows, short interest, and technical indicators — to build a more complete picture of market sentiment around AbbVie Inc..